L-asparaginase-induced hypofibrinogenemia: A case report

O. Balaji, D. Amita, P. Navin

Research output: Contribution to journalArticlepeer-review


Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.

Original languageEnglish
Pages (from-to)11-12
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Issue number5
Publication statusPublished - 01-01-2017
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)


Dive into the research topics of 'L-asparaginase-induced hypofibrinogenemia: A case report'. Together they form a unique fingerprint.

Cite this